Pfizer

Traded on the St. Petersburg Stock Exchange
Pfizer is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor, used to lower LDL blood cholesterol. The most famous brands are: "Lyrica", "Diflucan", " Zithromax", "Viagra", "Celebrex".
Pfizer stock price chart
+41%
P/E adj.
Net profit (adj.)
P/B
Book value
Debts
Net debt
Yield
Growth potential

Pfizer balance sheet

Report period2016 2017 2018 2019 2020 Q3 21
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Pfizer cash flows

Report period2016 2017 2018 2019 2020 Q3 21 TTM
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Pfizer multipliers

Report period2016 2017 2018 2019 2020 Q3 21 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Pfizer profitability

Report period2016 2017 2018 2019 2020 Q3 21 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Pfizer assets
Pfizer cash flows
Pfizer dividends
3.83%

Pfizer shares

TickerNameРазмер выпускаNominal valueISINPrice
PFE:USPfizer Inc.--US7170811035$54
PFE-RM:RMPfizer (MOEX)5,606,688,356 pcs.$0.05US7170811035RUB 4,064

Pfizer expected events

DateTypeNoteSource
06.12.2021 00:00
Dividends
The company will pay dividends of $0.39 per common share for Q4 Fiscal Year 2021.Pictogram of investors.pfizer.com  investors.pfizer.com
Pfizer news
25.11.2021
CHMP has recommended that the indication for COVID-19 vaccine from Pfizer-BioNTech be expanded to children 5 to 11 years of age. The immunization is proposed to be administered in two doses of 10 mcg, three weeks apart. CHMP will now send its recommendation to the European Commission, which will make the final decision.
19.11.2021
Canada has approved Pfizer's COVID-19 vaccine for children aged 5 to 11 years. It is the first vaccine approved in the country for children. Last month, Canada signed an agreement with Pfizer to supply 2.9 million doses of the drug.
19.11.2021
FDA has expanded the use of the Pfizer-BioNTech booster vaccine from COVID-19. It can now be given to people 18 years of age and older 6 months after the completion of the initial vaccination. Previously, the FDA had only allowed the booster to be used for people 65 years of age or older, and for people 18 to 64 years of age with a high risk of severe corona...
19.11.2021
European Commission has approved Pfizer's Xeljanz. The drug is intended to treat adults with active ankylosing spondylitis who have inadequately responded to conventional therapy.
General information
Company namePfizer, Inc
Tags#pharmacy, #top foreign stocks, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address235 E 42ND ST NEW YORK NY 10017 2125732323
Mailing address235 E 42ND ST NEW YORK NY 10017
Websiteinvestors.pfizer.com
Information disclosurewww.sec.gov